69 related articles for article (PubMed ID: 19815036)
1. Nanovehicles for enhanced oral delivery of taxanes.
Park K
J Control Release; 2009 Dec; 140(2):77-8. PubMed ID: 19815036
[No Abstract] [Full Text] [Related]
2. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.
Gaucher G; Marchessault RH; Leroux JC
J Control Release; 2010 Apr; 143(1):2-12. PubMed ID: 19925835
[TBL] [Abstract][Full Text] [Related]
3. [ Development of new taxane formulations].
Haas H
Pharm Unserer Zeit; 2005; 34(2):115-21. PubMed ID: 15803795
[No Abstract] [Full Text] [Related]
4. [Administration of taxane-containing drugs].
Barth J
Pharm Unserer Zeit; 2005; 34(2):152-8. PubMed ID: 15803800
[No Abstract] [Full Text] [Related]
5. [Biotransformation of taxanes].
Zhang LP; Cheng KD; Zhu P
Yao Xue Xue Bao; 2004 Feb; 39(2):153-7. PubMed ID: 15127627
[No Abstract] [Full Text] [Related]
6. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel from primary taxanes: a perspective on creative invention in organozirconium chemistry.
Ganem B; Franke RR
J Org Chem; 2007 May; 72(11):3981-7. PubMed ID: 17381159
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of solid lipid nanoparticles of norcantharidin].
Tian HY; Zhai GX
Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
10. Radiation interactions with taxanes, old and new.
Mason KA
Radiat Res; 2005 Jun; 163(6):705-6. PubMed ID: 16044506
[No Abstract] [Full Text] [Related]
11. Taxoids: cancer-fighting compounds from nature.
Kingston DG; Newman DJ
Curr Opin Drug Discov Devel; 2007 Mar; 10(2):130-44. PubMed ID: 17436548
[TBL] [Abstract][Full Text] [Related]
12. Nanocarriers.
Torchilin VP
Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
[TBL] [Abstract][Full Text] [Related]
13. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
[TBL] [Abstract][Full Text] [Related]
14. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis.
Roger E; Lagarce F; Garcion E; Benoit JP
J Control Release; 2009 Dec; 140(2):174-81. PubMed ID: 19699246
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery.
Miller ML; Roller EE; Zhao RY; Leece BA; Ab O; Baloglu E; Goldmacher VS; Chari RV
J Med Chem; 2004 Sep; 47(20):4802-5. PubMed ID: 15369381
[TBL] [Abstract][Full Text] [Related]
17. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: II. In vitro transport study.
Rao SV; Agarwal P; Shao J
Int J Pharm; 2008 Oct; 362(1-2):10-5. PubMed ID: 18640797
[TBL] [Abstract][Full Text] [Related]
18. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery.
Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX
J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718
[TBL] [Abstract][Full Text] [Related]
19. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
20. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
